Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 12 2021
Historique:
received: 23 05 2021
accepted: 14 12 2021
entrez: 25 12 2021
pubmed: 26 12 2021
medline: 1 2 2022
Statut: epublish

Résumé

Schizophrenia (SCZ) is a serious psychiatric condition with a 1% lifetime risk. SCZ is one of the top ten global causes of disabilities. Despite numerous attempts to understand the function of genetic factors in SCZ development, genetic components in SCZ pathophysiology remain unknown. The competing endogenous RNA (ceRNA) network has been demonstrated to be involved in the development of many kinds of diseases. The ceRNA hypothesis states that cross-talks between coding and non-coding RNAs, including long non-coding RNAs (lncRNAs), via miRNA complementary sequences known as miRNA response elements, creates a large regulatory network across the transcriptome. In the present study, we developed a lncRNA-related ceRNA network to elucidate molecular regulatory mechanisms involved in SCZ. Microarray datasets associated with brain regions (GSE53987) and lymphoblasts (LBs) derived from peripheral blood (sample set B from GSE73129) of SCZ patients and control subjects containing information about both mRNAs and lncRNAs were downloaded from the Gene Expression Omnibus database. The GSE53987 comprised 48 brain samples taken from SCZ patients (15 HPC: hippocampus, 15 BA46: Brodmann area 46, 18 STR: striatum) and 55 brain samples taken from control subjects (18 HPC, 19 BA46, 18 STR). The sample set B of GSE73129 comprised 30 LB samples (15 patients with SCZ and 15 controls). Differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) were identified using the limma package of the R software. Using DIANA-LncBase, Human MicroRNA Disease Database (HMDD), and miRTarBase, the lncRNA- associated ceRNA network was generated. Pathway enrichment of DEmRNAs was performed using the Enrichr tool. We developed a protein-protein interaction network of DEmRNAs and identified the top five hub genes by the use of STRING and Cytoscape, respectively. Eventually, the hub genes, DElncRNAs, and predictive miRNAs were chosen to reconstruct the subceRNA networks. Our bioinformatics analysis showed that twelve key DEmRNAs, including BDNF, VEGFA, FGF2, FOS, CD44, SOX2, NRAS, SPARC, ZFP36, FGG, ELAVL1, and STARD13, participate in the ceRNA network in SCZ. We also identified DLX6-AS1, NEAT1, MINCR, LINC01094, DLGAP1-AS1, BABAM2-AS1, PAX8-AS1, ZFHX4-AS1, XIST, and MALAT1 as key DElncRNAs regulating the genes mentioned above. Furthermore, expression of 15 DEmRNAs (e.g., ADM and HLA-DRB1) and one DElncRNA (XIST) were changed in both the brain and LB, suggesting that they could be regarded as candidates for future biomarker studies. The study indicated that ceRNAs could be research candidates for investigating SCZ molecular pathways.

Identifiants

pubmed: 34952924
doi: 10.1038/s41598-021-03993-3
pii: 10.1038/s41598-021-03993-3
pmc: PMC8709859
doi:

Substances chimiques

Biomarkers 0
RNA, Long Noncoding 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24413

Informations de copyright

© 2021. The Author(s).

Références

Biochim Biophys Acta. 2016 Jan;1859(1):16-22
pubmed: 26297315
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Psychiatr Clin North Am. 2010 Mar;33(1):35-66
pubmed: 20159339
JAMA Psychiatry. 2020 Feb 1;77(2):201-210
pubmed: 31664453
Transl Psychiatry. 2019 May 23;9(1):151
pubmed: 31123247
Cells. 2019 Nov 06;8(11):
pubmed: 31698752
BMC Neurosci. 2018 Apr 19;19(Suppl 1):22
pubmed: 29745862
Nucleic Acids Res. 2019 Jan 8;47(D1):D1013-D1017
pubmed: 30364956
Clin Infect Dis. 2003 Jul 1;37(1):82-7
pubmed: 12830412
Neurosci Lett. 2018 Nov 1;686:28-32
pubmed: 30172685
Biol Psychiatry. 2009 Jun 15;65(12):1006-14
pubmed: 19121517
Neurochem Res. 2018 Feb;43(2):441-448
pubmed: 29214513
Patterns (N Y). 2021 Mar 04;2(3):100213
pubmed: 33748796
Eur Arch Psychiatry Clin Neurosci. 2014 Aug;264(5):423-32
pubmed: 24241531
Onco Targets Ther. 2020 Oct 06;13:9917-9928
pubmed: 33116576
Front Mol Neurosci. 2018 Oct 05;11:370
pubmed: 30344479
PLoS One. 2012;7(10):e46368
pubmed: 23118852
BMC Syst Biol. 2014;8 Suppl 4:S11
pubmed: 25521941
Int J Mol Sci. 2017 Mar 30;18(4):
pubmed: 28358316
EMBO J. 2010 Sep 15;29(18):3082-93
pubmed: 20729808
Mol Autism. 2017 Mar 20;8:11
pubmed: 28321286
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Nucleic Acids Res. 2020 Jan 8;48(D1):D148-D154
pubmed: 31647101
Nucleic Acids Res. 2019 Jan 8;47(D1):D786-D792
pubmed: 30304474
Neurosci Lett. 2021 Feb 16;746:135669
pubmed: 33485989
Biol Psychiatry. 2011 Jan 15;69(2):157-62
pubmed: 20801428
Mol Psychiatry. 2013 Feb;18(2):133
pubmed: 23344565
Biostatistics. 2003 Apr;4(2):249-64
pubmed: 12925520
Aust N Z J Psychiatry. 2012 Jul;46(7):598-610
pubmed: 22441207
Behav Brain Res. 2021 Jan 1;396:112876
pubmed: 32846206
Mol Cell. 2014 Sep 4;55(5):791-802
pubmed: 25155612
Front Psychiatry. 2020 May 07;11:392
pubmed: 32457667
Schizophr Bull. 2013 Mar;39(2):396-406
pubmed: 22228753
Nat Commun. 2017 Oct 13;8(1):909
pubmed: 29030541
Development. 2013 Nov;140(21):4407-16
pubmed: 24089468
Aging (Albany NY). 2021 Apr 26;13(8):12129-12142
pubmed: 33901010
Mol Psychiatry. 2013 Feb;18(2):215-25
pubmed: 22212594
Genome Biol. 2007;8(2):R27
pubmed: 17326821
CNS Neurol Disord Drug Targets. 2015;14(2):208-21
pubmed: 25613509
Mol Psychiatry. 2010 Dec;15(12):1176-89
pubmed: 19721432
Genome Med. 2017 Jul 28;9(1):72
pubmed: 28754123
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Eur J Neurosci. 2021 Jun;53(12):3960-3987
pubmed: 33070392
Gen Hosp Psychiatry. 2019 Nov - Dec;61:41-46
pubmed: 31710857
N Engl J Med. 2019 Oct 31;381(18):1753-1761
pubmed: 31665579
Cell Mol Neurobiol. 2021 Mar 12;:
pubmed: 33712885
Schizophr Res Treatment. 2020 May 31;2020:5176834
pubmed: 32566292
Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):261-8
pubmed: 16526044
Cancer Gene Ther. 2019 Nov;26(11-12):374-387
pubmed: 30546116
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3125-30
pubmed: 22315408
Neurochem Res. 2020 Jul;45(7):1690-1699
pubmed: 32333234
Psychiatr Genet. 2016 Jun;26(3):109-16
pubmed: 26974119
Sci Rep. 2019 Sep 4;9(1):12737
pubmed: 31484957
Transl Psychiatry. 2018 Oct 11;8(1):215
pubmed: 30310054
Brain Res. 2008 Nov 6;1239:235-48
pubmed: 18778695
Cell. 2011 Aug 5;146(3):353-8
pubmed: 21802130
Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):557-64
pubmed: 18081029
Front Genet. 2019 Mar 22;10:232
pubmed: 30967896
Cell Mol Neurobiol. 2019 Mar;39(2):211-221
pubmed: 30560506
Nucleic Acids Res. 2020 Jan 8;48(D1):D101-D110
pubmed: 31732741
J Psychiatr Res. 2018 Nov;106:22-30
pubmed: 30243133
J Cell Physiol. 2018 Jan;233(1):530-548
pubmed: 28300292
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Front Psychiatry. 2021 Jun 18;12:640463
pubmed: 34220567
J Psychopharmacol. 2012 Mar;26(3):374-9
pubmed: 21693553
Genome Biol. 2014 Jan 08;15(1):R12
pubmed: 24401661
Biosci Rep. 2019 Mar 28;39(3):
pubmed: 30833361
Biosci Rep. 2021 Feb 26;41(2):
pubmed: 33470407
Sci Rep. 2020 Oct 30;10(1):18770
pubmed: 33128008
Transl Psychiatry. 2021 Feb 8;11(1):117
pubmed: 33558459
NPJ Schizophr. 2019 Jan 29;5(1):3
pubmed: 30696826
Neuroimaging Clin N Am. 2020 Feb;30(1):73-83
pubmed: 31759574
Psychiatry Res. 2018 Jul;265:25-38
pubmed: 29680514
Cells. 2020 Jun 28;9(7):
pubmed: 32605220
Neuroscience. 2010 May 5;167(2):384-95
pubmed: 20138973
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Mol Psychiatry. 2013 Feb;18(2):206-14
pubmed: 22869038
Neurosci Lett. 2020 Aug 24;734:135100
pubmed: 32473196
BMC Genomics. 2014;15 Suppl 9:S6
pubmed: 25522158
J Mol Neurosci. 2019 Feb;67(2):276-281
pubmed: 30565169
Bioinformatics. 2001 Sep;17(9):763-74
pubmed: 11590094
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
Nat Neurosci. 2018 Jan;21(1):130-138
pubmed: 29203896
Mol Neurobiol. 2017 Mar;54(2):1577-1586
pubmed: 27221610
Transl Psychiatry. 2016 Oct 11;6(10):e915
pubmed: 27727244
Handb Exp Pharmacol. 2014;220:223-50
pubmed: 24668475
World J Psychiatry. 2016 Mar 22;6(1):102-17
pubmed: 27014601
Mol Med Rep. 2019 May;19(5):3411-3420
pubmed: 30864711
Mol Neuropsychiatry. 2018 May;3(4):197-213
pubmed: 29888231
Biol Psychiatry. 2011 Jan 15;69(2):180-7
pubmed: 21111402
Mol Biol Cell. 2014 Jan;25(1):169-83
pubmed: 24173718
Noncoding RNA. 2018 Apr 12;4(2):
pubmed: 29657307
Psychiatry Res. 2014 May 15;216(2):192-7
pubmed: 24560611
Sci Transl Med. 2018 Dec 19;10(472):
pubmed: 30545965

Auteurs

Hani Sabaie (H)

Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Madiheh Mazaheri Moghaddam (MM)

Department of Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences (ZUMS), Zanjan, Iran.

Marziyeh Mazaheri Moghaddam (MM)

Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Noora Karim Ahangar (NK)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Reza Asadi (MR)

Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Bashdar Mahmud Hussen (BM)

Department of Pharmacognosy, College of Pharmacy, Hawler Medical University, Kurdistan Region, Erbil, Iraq.

Mohammad Taheri (M)

Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Mohammad_823@yahoo.com.

Maryam Rezazadeh (M)

Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Rezazadehm@tbzmed.ac.ir.
Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Rezazadehm@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH